We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2005;294(2):153. doi:10.1001/jama.294.2.153.
Text Size: A A A
Published online


Current recommendations for menopausal symptom management with hormone therapy encourage prescription of the lowest effective dosage for the shortest duration possible. However, few data exist regarding symptoms experienced when hormone therapy is discontinued. Ockene and colleaguesArticle report results of a survey completed by 8405 women (89.9% of those eligible) who were still taking their study medication (combined conjugated equine estrogens plus medroxyprogesterone acetate [CEE + MPA] or placebo) when the Women’s Health Initiative trial was stopped. Among their findings were that women formerly taking CEE + MPA reported more symptoms than women formerly taking placebo and that the presence of symptoms at baseline was associated with increased symptom reports after stopping either CEE + MPA or placebo. In an editorial, Petitti Article discusses symptoms of menopause, aging, and treatment options.


Incidence of hepatitis A following implementation of wide-scale vaccination programs is reported in 2 articles in this issue of JAMA. First, Wasley and colleaguesArticle compared the incidence of hepatitis A in the United States from 1990 to 1997—a period preceding recommendations for targeted vaccination of children and adults at risk—to that in 2003. They found a 76% decline of hepatitis A from the 1990-1997 rates to the 2003 rates. In the second article, Dagan and colleaguesArticle report hepatitis A incidence in Israel before and after a national immunization program for children 18 to 24 months of age. They found a more than 95% decline in overall hepatitis A incidence compared with rates before establishing the immunization program. In an editorial, Van Damme and Van HerckArticle discuss the contributions of national immunization programs and herd immunity to reductions in hepatitis A incidence.


Hospice care may improve the quality of end-of-life care for nursing home residents, but data suggest that hospice is underused. Casarett and colleagues conducted a randomized trial to determine whether a simple communication to the responsible physician could increase hospice use and improve care among patients whose care goals and needs were appropriate for hospice care. Residents in the intervention group, whose physician received a fax requesting authorization of a hospice informational visit, were more likely to enroll in hospice and had fewer acute care admissions and their family or surrogate rated their care more favorably than residents in the control group whose physicians were not informed of their suitability for hospice.

See Article


In uncontrolled studies of pediatric acute lung injury, prone positioning appeared to improve oxygenation, but its effects on ventilator-free days or clinical outcomes are not known. Curley and colleaguesArticle randomly assigned infants and children with acute lung injury to supine or prone positioning and assessed outcomes through 28 days. The trial was stopped when an interim analysis confirmed improved oxygenation but revealed no difference in ventilator-free days or clinical outcomes in children being placed in the prone position compared with those placed in the supine position. In an editorial, KavanaghArticle discusses implications of the trial outcomes for clinical practice and future investigations.


Scientists report that live vaccines targeting Ebola and Marburg viruses have successfully protected monkeys from infection, findings seen as an advance toward the development of effective human vaccines.

See Article


In subsequent well-designed investigations of clinical questions initially explored in highly cited research studies, contradictory results or effect sizes of smaller magnitude are not uncommon.

See Article


Risks and benefits of androgen deprivation therapy and treatment of adverse effects.

See Article


For your patients: Information about hepatitis A.

See Article



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.